Isoprenaline
| Clinical data | |
|---|---|
| Trade names | Isuprel, others[1][2] |
| Other names | Isoproterenol; Isopropylnorepinephrine; Isopropylnoradrenaline; Isopropydine; WIN-5162 |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a601236 |
| Pregnancy category |
|
| Routes of administration | Intravenous, intramuscular, subcutaneous, intracardiac, inhalation, sublingual, rectal[3][4] |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | Oral: Very low[5][6] |
| Protein binding | 69% (mostly to albumin)[3] |
| Metabolism | Methylation (COMT), conjugation (sulfation)[7][3] |
| Metabolites | • 3-O-Methylisoprenaline[3] • Sulfate conjugates[7] |
| Onset of action | Inhalation: 2–5 min[8] |
| Elimination half-life | IV: 2.5–5 min[3] Oral: 40 min[3] |
| Duration of action | Inhalation: 0.5–2 hours[8] |
| Excretion | Urine: 59–107%[3] Feces: 12–27%[3] |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.028.807 |
| Chemical and physical data | |
| Formula | C11H17NO3 |
| Molar mass | 211.261 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Isoprenaline, also known as isoproterenol and sold under the brand name Isuprel among others, is a sympathomimetic medication which is used in the treatment of acute bradycardia (slow heart rate), heart block, and rarely for asthma, among other indications.[9] It is used by injection into a vein, muscle, fat, or the heart, by inhalation, and in the past under the tongue or into the rectum.[3][4]
Side effects of isoprenaline include rapid heart beat, heart palpitations, and arrhythmias, among others.[9] Isoprenaline is a selective agonist of the β-adrenergic receptors, including both the β1- and β2-adrenergic receptors.[9] By activating these receptors, it increases heart rate and the force of heart contractions.[10] Chemically, isoprenaline is a synthetic catecholamine and is the N-isopropyl analogue of norepinephrine (noradrenaline) and epinephrine (adrenaline).[11][3][12][13]
Isoprenaline was one of the first synthetic sympathomimetic amines and was the first selective β-adrenergic receptor agonist.[7][14] The medication was discovered in 1940[5] and was introduced for medical use in 1947.[15]
- ^ Cite error: The named reference
IndexNominum2004was invoked but never defined (see the help page). - ^ Cite error: The named reference
Drugs.comwas invoked but never defined (see the help page). - ^ a b c d e f g h i j "Isoprenaline: Uses, Interactions, Mechanism of Action". DrugBank Online. 19 February 1948. Retrieved 31 July 2024.
- ^ a b "Drugs@FDA: FDA-Approved Drugs". accessdata.fda.gov. Archived from the original on November 4, 2016. Retrieved 31 July 2024.
- ^ a b Cite error: The named reference
Waldeck2002was invoked but never defined (see the help page). - ^ Cite error: The named reference
ConollyDaviesDollery1972was invoked but never defined (see the help page). - ^ a b c Cite error: The named reference
Morgan1990was invoked but never defined (see the help page). - ^ a b Cite error: The named reference
Sterling1995was invoked but never defined (see the help page). - ^ a b c "Label: Isoproterenol hydrochloride injection, solution". NIH DailyMed. September 10, 2013. Retrieved June 21, 2017.
- ^ Motwani SK, Saunders H (2024). "Inotropes". Anaesthesia & Intensive Care Medicine. 25 (3): 185–191. doi:10.1016/j.mpaic.2023.11.019.
- ^ Cite error: The named reference
PubChemwas invoked but never defined (see the help page). - ^ Cite error: The named reference
ChemSpiderwas invoked but never defined (see the help page). - ^ Cite error: The named reference
Konzett1981was invoked but never defined (see the help page). - ^ Cite error: The named reference
RuženaJindraRenáta2020was invoked but never defined (see the help page). - ^ Cite error: The named reference
MozayaniRaymon2003was invoked but never defined (see the help page).